Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05024825Phase 4Terminated
Phase 4, randomised, open-label trial of gabapentin in pain (2 arms), sponsored by Albany Medical College. Primary endpoint: Total opioid equivalent dose at 7 days. Started Aug 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05024825.